Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012

GlobalData, January 2012, Pages: 118

Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012" provides data on the Rhabdomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rhabdomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rhabdomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Rhabdomyosarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Rhabdomyosarcoma , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Rhabdomyosarcoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Rhabdomyosarcoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Rhabdomyosarcoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Jennerex Biotherapeutics, Inc.
Clinical Trial Overview of Jennerex Biotherapeutics, Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Children's Memorial Hospital
Clinical Trial Overview of Children's Memorial Hospital
Medical College of Wisconsin
Clinical Trial Overview of Medical College of Wisconsin
Hospital Santa Marcelina
Clinical Trial Overview of Hospital Santa Marcelina
European Paediatric Soft Tissue Sarcoma Study Group
Clinical Trial Overview of European Paediatric Soft Tissue Sarcoma Study Group
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sarcoma Alliance for Research through Collaboration
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
Centre Oscar Lambret
Clinical Trial Overview of Centre Oscar Lambret
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Emory University
Clinical Trial Overview of Emory University
University Hospital Basel
Clinical Trial Overview of University Hospital Basel
Stanford University
Clinical Trial Overview of Stanford University
Penn State University
Clinical Trial Overview of Penn State University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, BRIC Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, G7 Countries, 2012-
Rhabdomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, E7 Countries, 2012-
Rhabdomyosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Memorial Hospital, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Santa Marcelina, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Paediatric Soft Tissue Sarcoma Study Group, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-

List of Figures
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, G7 Countries (%), 2012-
Rhabdomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Non-Rhabdomyosarcoma - Pipeline Review, H2 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Cholangitis Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Ulcers Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Alopecia Global Clinical Trials Review, H1, 2013
• Cachexia Global Clinical Trials Review, H1, 2013
• Hemostasis Global Clinical Trials Review, H1, 2013